Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation

References

• CheniteAChaputCWangDNovel injectable neutral solutions of chitosan form biodegradable gels in situBiomaterials200021212155216110985488
   PubMed Web of Science ®Google Scholar
• PackhaeuserCBSchniedersJOsterCGKisselTIn situ forming parenteral drug delivery systems: an overviewEur J Pharm Biopharm200458244545515296966
   PubMed Web of Science ®Google Scholar
• AhmedTAApproaches to develop PLGA based in situ gelling system with low initial burstPak J Pharm Sci201528265766525730797
   PubMed Web of Science ®Google Scholar
• RodriguesSCordeiroCSeijoBRemuñán-LópezCGrenhaAHybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: stability and toxicological evaluationCarbohydr Polym201512336938025843870
   PubMed Web of Science ®Google Scholar
• KranzHBrazeauGANapapornJMartinRLMillardWBodmeierRMyotoxicity studies of injectable biodegradable in-situ forming drug delivery systemsInt J Pharm20012121111811165816
   PubMedGoogle Scholar
• AhmedTAIbrahimHMIbrahimFDevelopment of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidolJ Pharm Sci2012101103753376222753324
   PubMed Web of Science ®Google Scholar
• AhmedTAIbrahimHMSamyAMKaseemANutanMTHHussainMDBiodegradable injectable in situ implants and microparticles for sustained release of Montelukast: in vitro release, pharmacokinetics, and stabilityAAPS PharmSciTech201415377278024648158
   PubMed Web of Science ®Google Scholar
• MallapragadaSKPeppasNAColomboPCrystal dissolution-controlled release systems. II. Metronidazole release from semicrystalline poly(vinyl alcohol) systemsJ Biomed Mater Res19973611251309212397
   PubMed Web of Science ®Google Scholar
• PekarekKJJacobJSMathiowitzEDouble-walled polymer microspheres for controlled drug releaseNature199436764602582608121490
   PubMed Web of Science ®Google Scholar
• GrahamPBrodbeckKMcHughAPhase inversion dynamics of PLGA solutions related to drug deliveryJ Control Release199958223324510053196
   PubMed Web of Science ®Google Scholar
• XinCLihongWQiuyuanLHongzhuoLInjectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: preparation, in vitro and in vivo evaluationInt J Pharm20144691233024751344
   PubMedGoogle Scholar
• PatelRBCarlsonANSolorioLExnerAACharacterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systemsJ Biomed Mater Res A201094247648420186771
   PubMedGoogle Scholar
• KempeSMäderKIn situ forming implants – an attractive formulation principle for parenteral depot formulationsJ Control Release2012161266867922543012
   PubMed Web of Science ®Google Scholar
• IbrahimHMAhmedTAHussainMDDevelopment of meloxicam in situ implant formulation by quality by design principleDrug Dev Ind Pharm2013904518
   Google Scholar
• TanLPVenkatramanSSSungPFWangXTEffect of plasticization on heparin release from biodegradable matricesInt J Pharm20042831–2899615363505
   PubMedGoogle Scholar
• GoldsteinJLBrownMSRegulation of the mevalonate pathwayNature199034362574254301967820
   PubMed Web of Science ®Google Scholar
• PekkanenJLinnSHeissGTen-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular diseaseN Engl J Med199032224170017072342536
   PubMed Web of Science ®Google Scholar
• LennernäsHClinical pharmacokinetics of atorvastatinClin Pharmacokinet200342131141116014531725
   PubMed Web of Science ®Google Scholar
• WagnerJGInterpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsulesJ Pharm Sci19695810125312575349114
   PubMed Web of Science ®Google Scholar
• DesaiSSinghPSimonelliAHiguchiWInvestigation of factors influencing release of solid drug dispersed in inert matrices III. Quantitative studies involving the polyethylene plastic matrixJ Pharm Sci19665511123012345969777
   PubMed Web of Science ®Google Scholar
• HiguchiTMechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJ Pharm Sci196352121145114914088963
   PubMed Web of Science ®Google Scholar
• KorsmeyerRGurnyRDoelkerEBuriPPeppasNMechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped airJ Pharm Sci1983151118911916644570
   PubMedGoogle Scholar
• RitgerPPeppasNA simple equation for description of solute release. II. Fickian and anomalous release from swellable devicesJ Control Release198753742
   Google Scholar
• KurakulaMAhmedTACo-delivery of atorvastatin nanocrystals in PLGA based in situ gel for anti-hyperlipidemic efficacyCurr Drug Deliv Epub2015118
   Web of Science ®Google Scholar
• Reagan-ShawSNihalMAhmadNDose translation from animal to human studies revisitedFASEB J200822365966117942826
   PubMed Web of Science ®Google Scholar
• GajulaRPilliNRRaviVBSimultaneous determination of atorvastatin and aspirin in human plasma by LC-MS/MS: its pharmacokinetic applicationSci Pharm201280492394023264940
   PubMedGoogle Scholar
• D’SouzaSSFarajJADeLucaPPA model-dependent approach to correlate accelerated with real-time release from biodegradable microspheresAAPS PharmSciTech200564E553E56416408857
   PubMed Web of Science ®Google Scholar
• WangLVenkatramanSKleinerLDrug release from injectable depots: two different in vitro mechanismsJ Control Release200499220721615380631
   PubMed Web of Science ®Google Scholar
• ShiveMAndersonJBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev199728152410837562
   PubMed Web of Science ®Google Scholar
• JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials200021232475249011055295
   PubMed Web of Science ®Google Scholar
• FredenbergSWahlgrenMReslowMAxelssonAThe mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems – a reviewInt J Pharm20114151–2345221640806
   PubMed Web of Science ®Google Scholar
• TangYSinghJControlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systemsInt J Pharm20083571–211912518329202
   PubMedGoogle Scholar
• Elias-Al-MamunMKhanHADewanIJalilR-UIn vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implantsPak J Pharm Sci200922436036719783512
   PubMed Web of Science ®Google Scholar
• AlimohammadiSSalehiRAminiNDavaranSSynthesis and physicochemical characterization of biodegradable PLGA-based magnetic nanoparticles containing amoxicilinBull Korean Chem Soc2012331032253232
   Web of Science ®Google Scholar
• DeadmanCMKellawayIWYasinMDickinsonPAMurdanSAn investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depotsJ Control Release20071221798517638603
   PubMed Web of Science ®Google Scholar
• VintiloiuALafleurMBastiatGLerouxJ-CIn situ-forming oleogel implant for rivastigmine deliveryPharm Res200825484585217694395
   PubMed Web of Science ®Google Scholar
• LuanXBodmeierRModification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticlesEur J Pharm Biopharm200663220521416621485
   PubMed Web of Science ®Google Scholar
• GrassiMGrassiGMathematical modelling and controlled drug delivery: matrix systemsCurr Drug Deliv2005219711616305412
   PubMedGoogle Scholar
• ShoaibMHTazeenJMerchantHAYousufRIEvaluation of drug release kinetics from ibuprofen matrix tablets using HPMCPak J Pharm Sci200619211912416751122
   PubMedGoogle Scholar